Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 PatientsFrancesca Minoia, Angelo Ravelli, Sergio Davì et al.|Arthritis & Rheumatology|2014Cited by 430
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritisFrancesca Minoia, Angelo Ravelli, Francesca Bovis et al.|Annals of the Rheumatic Diseases|2019Cited by 109
Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trialAngelo Ravelli, Alberto Martini, Giovanni Filocamo et al.|The Lancet|2017Cited by 69
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanerceptAngelo Ravelli, Sara Verazza, Sergio Davì et al.|Pediatric Rheumatology|2016Cited by 41